Medtronic Presents One-Year Data on Endurant(R) Stent Graft

The Endurant(R) Stent Graft System used for abdominal aortic aneurysms, from Medtronic, Inc., delivered strong results through one year of patient follow-up in the company's U.S. pivotal study, according to clinical data presented at VEITHsymposium(TM).

Approved by the U.S. Food and Drug Administration (FDA) under an investigational device exemption (IDE), the prospective study involved 150 patients at 26 U.S. medical centers and met its primary endpoints. In the study, the Endurant System was associated with no post-operative aneurysm ruptures or aneurysm-related mor...talities at one year, and there were no mortalities from any cause at 30 days.

It received the CE (Conformite Europeene) mark in July 2008.